Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Adamis Pharmaceuticals Corporation ADMP
$0.08
+$0 (1.13%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
13152158.00000000
-
week52high
0.55
-
week52low
0.07
-
Revenue
4756078
-
P/E TTM
0
-
Beta
1.22871900
-
EPS
-0.17000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мая 2023 г. в 10:59
Описание компании
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Maxim Group | Buy | Hold | 13 мая 2020 г. |
| Raymond James | Market Perform | Outperform | 26 ноя 2019 г. |
| Maxim Group | Hold | Buy | 25 ноя 2019 г. |
| B. Riley FBR | Neutral | Sell | 23 июл 2019 г. |
| B. Riley | Sell | Neutral | 16 июл 2019 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| BIRNDORF HOWARD C | A | 58824 | 58824 | 14 ноя 2022 г. |
| BIRNDORF HOWARD C | A | 0 | 58824 | 14 ноя 2022 г. |
| CARLO DENNIS J PHD | D | 0 | 250000 | 25 мая 2022 г. |
| CARLO DENNIS J PHD | A | 535867 | 250000 | 25 мая 2022 г. |
| REED VICKIE S | A | 50000 | 50000 | 24 мая 2022 г. |
| Moss Ronald B. | D | 201911 | 8199 | 18 мар 2022 г. |
| CARLO DENNIS J PHD | D | 285867 | 10490 | 18 мар 2022 г. |
| Marguglio David J. | D | 233906 | 11859 | 18 мар 2022 г. |
| Benedicto David C. | D | 39875 | 3603 | 18 мар 2022 г. |
| Marguglio David J. | D | 245765 | 13000 | 09 дек 2021 г. |
Новостная лента
Adamis Pharmaceuticals Corporation (ADMP) Q4 2022 Earnings Call Transcript
Seeking Alpha
17 мар 2023 г. в 16:50
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP ) Q4 2022 Results Conference Call March 16, 2023 5:00 PM ET Company Participants Robert Uhl - MD, ICR Westwicke David Marguglio - CEO David Benedicto - CFO Dr. Eboo Versi - CEO, DMK Pharmaceuticals Conference Call Participants Operator Greetings, and welcome to the Adamis Pharmaceuticals Full Year 2022 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update
GlobeNewsWire
14 мар 2023 г. в 16:01
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory disease, today announced that it will host an investor conference call on Thursday, March 16, 2023 at 2:00 p.m. PT to discuss its financial and operating results for the fourth quarter and full year 2022 as well as provide a corporate update. The company's fourth quarter and full year 2022 financial results news release is expected to be available after 1 p.m. PT on March 16, 2023, and on its website .
Adamis Pharmaceuticals (ADMP) Stock Wavers on Merger News
InvestorPlace
28 февр 2023 г. в 10:45
It's an unusual day for Adamis Pharmaceuticals (NASDAQ: ADMP ) stock traders, to say the least. That's because the company recently announced its intent to acquire DMK Pharmaceuticals.
How to Diversify Your Penny Stock Investments
PennyStocks
12 февр 2023 г. в 11:00
Use these tips for diversifying your investments in penny stocks The post How to Diversify Your Penny Stock Investments appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Adamis Pharmaceuticals Corporation (ADMP) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 22:03
Adamis Pharmaceuticals Corporation (NASDAQ:ADMP ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants Robert Uhl - Westwicke Partners David Marguglio - Co-Founder, CEO, President & Director David Benedicto - CFO Conference Call Participants Operator Good afternoon, ladies and gentlemen, and welcome to the Adamis Pharmaceuticals' Third Quarter 2020 Financial Results Conference Call. [Operator Instructions].